We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Yext
YEXT
$564M
| $1.97M | ﹤0.01% |
367,953
+256,688
| +231% | +$1.38M |
|
1352
Supernus Pharmaceuticals
SUPN
$2.77B
| $1.97M | ﹤0.01% |
+73,519
| New | +$2.13M |
|
1353
Paymentus
PAY
$4.29B
| $1.96M | ﹤0.01% |
103,411
-58,820
| -36% | -$1.15M |
|
1354
Sonic Automotive
SAH
$3.31B
| $1.96M | ﹤0.01% |
35,969
+32,106
| +831% | +$1.78M |
|
1355
KB Financial Group
KB
$40.6B
| $1.96M | ﹤0.01% |
34,603
-23,746
| -41% | -$1.29M |
|
1356
MaxCyte
MXCT
$112M
| $1.96M | ﹤0.01% |
+499,669
| New | +$2.15M |
|
|
AAN
1357
DELISTED
The Aaron's Company Inc
AAN
| $1.96M | ﹤0.01% |
+196,157
| New | +$1.53M |
|
1358
CALL
Netflix
NFLX
$301B
| $1.96M | ﹤0.01% |
29,000
-829,000
| -97% | -$51.8M |
|
1359
Toll Brothers
TOL
$14.5B
| $1.96M | ﹤0.01% |
16,990
-158,270
| -90% | -$19.2M |
|
|
ZYXI
1360
DELISTED
Zynex
ZYXI
| $1.96M | ﹤0.01% |
209,865
-54,323
| -21% | -$578K |
|
1361
LifeMD
LFMD
$186M
| $1.95M | ﹤0.01% |
284,766
-352
| -0.1% | -$3.22K |
|
|
EHAB
1362
DELISTED
Enhabit
EHAB
| $1.94M | ﹤0.01% |
+217,616
| New | +$2.08M |
|
1363
Capital Southwest
CSWC
$1.48B
| $1.94M | ﹤0.01% |
+74,253
| New | +$1.91M |
|
|
BBBY
1364
Bed Bath & Beyond
BBBY
$503M
| $1.94M | ﹤0.01% |
162,763
-371,869
| -70% | -$6.6M |
|
1365
Baytex Energy
BTE
$2.86B
| $1.93M | ﹤0.01% |
555,553
+394,813
| +246% | +$1.41M |
|
1366
Rekor Systems
REKR
$86.9M
| $1.93M | ﹤0.01% |
1,243,821
-41,906
| -3% | -$73.3K |
|
1367
Bread Financial
BFH
$4.36B
| $1.91M | ﹤0.01% |
42,948
+33,848
| +372% | +$1.33M |
|
1368
Bausch + Lomb
BLCO
$5.92B
| $1.91M | ﹤0.01% |
+131,624
| New | +$1.98M |
|
1369
Bioventus
BVS
$895M
| $1.91M | ﹤0.01% |
332,291
+91,843
| +38% | +$504K |
|
1370
Napco Security Technologies
NSSC
$1.33B
| $1.9M | ﹤0.01% |
36,661
-167,156
| -82% | -$7.65M |
|
1371
PUT
Eli Lilly
LLY
$1.09T
| $1.9M | ﹤0.01% |
2,100
-300
| -13% | -$240K |
|
1372
Gold Fields
GFI
$29.2B
| $1.9M | ﹤0.01% |
+127,401
| New | +$2.07M |
|
1373
CALL
Walt Disney
DIS
$172B
| $1.9M | ﹤0.01% |
19,100
-1,700
| -8% | -$183K |
|
1374
Actinium Pharmaceuticals
ATNM
$27.2M
| $1.89M | ﹤0.01% |
256,026
+103,557
| +68% | +$853K |
|
1375
Invesco NASDAQ 100 ETF
QQQM
$94.9B
| $1.89M | ﹤0.01% |
+9,596
| New | +$1.78M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.